These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 12735985

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Anti-HIV-1 activity of benzothiadiazine dioxide.
    Martinez A, Gil C, Castro A, Perez C, Witvrouw M, Pannecouque C, Balzarini J, De Clercq E.
    Antivir Chem Chemother; 2001 Nov; 12(6):347-51. PubMed ID: 12018679
    [Abstract] [Full Text] [Related]

  • 5. Good oral absorption prediction on non-nucleoside benzothiadiazine dioxide human cytomegalovirus inhibitors using combined chromatographic and neuronal network techniques.
    Gil C, Dorronsoro I, Castro A, Martinez A.
    Bioorg Med Chem Lett; 2005 Apr 01; 15(7):1919-21. PubMed ID: 15780633
    [Abstract] [Full Text] [Related]

  • 6. Benzothiadiazine dioxide dibenzyl derivatives as potent human cytomegalovirus inhibitors: synthesis and comparative molecular field analysis.
    Martinez A, Gil C, Abasolo MI, Castro A, Bruno AM, Perez C, Prieto C, Otero J.
    J Med Chem; 2000 Aug 24; 43(17):3218-25. PubMed ID: 10966740
    [Abstract] [Full Text] [Related]

  • 7. Chlorophenylmethyl benzothiadiazine dioxides derivatives: potent human cytomegalovirus inhibitors.
    Martinez A, Gil C, Perez C, Castro A, Prieto C, Otero J.
    Bioorg Med Chem Lett; 1999 Nov 01; 9(21):3133-6. PubMed ID: 10560739
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Recent advances in antiviral activity of benzo/heterothiadiazine dioxide derivatives.
    Zhan P, Liu X, De Clercq E.
    Curr Med Chem; 2008 Nov 01; 15(15):1529-40. PubMed ID: 18537628
    [Abstract] [Full Text] [Related]

  • 10. 4"-Benzoylureido-TSAO derivatives as potent and selective non-nucleoside HCMV inhibitors. Structure-activity relationship and mechanism of antiviral action.
    de Castro S, Peromingo MT, Naesens L, Andrei G, Snoeck R, Balzarini J, Velázquez S, Camarasa MJ.
    J Med Chem; 2008 Sep 25; 51(18):5823-32. PubMed ID: 18707089
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and ++thiosangivamycin: influence of various 7-substituents on antiviral activity.
    Renau TE, Wotring LL, Drach JC, Townsend LB.
    J Med Chem; 1996 Feb 16; 39(4):873-80. PubMed ID: 8632411
    [Abstract] [Full Text] [Related]

  • 17. From 1-acyl-beta-lactam human cytomegalovirus protease inhibitors to 1-benzyloxycarbonylazetidines with improved antiviral activity. A straightforward approach to convert covalent to noncovalent inhibitors.
    Gerona-Navarro G, Pérez de Vega MJ, García-López MT, Andrei G, Snoeck R, De Clercq E, Balzarini J, González-Muñiz R.
    J Med Chem; 2005 Apr 07; 48(7):2612-21. PubMed ID: 15801851
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. 3-Benzamido, ureido and thioureidoimidazo[1,2-a]pyridine derivatives as potential antiviral agents.
    Chaouni-Enabdallah A, Galtier C, Allouchi H, Kherbeche A, Chavignon O, Teulade JC, Witvrouw M, Pannecouque C, Snoeck R, Andrei G, Balzarini J, De Clercq E, Fauvelle F, Enguehard C, Gueiffier A.
    Chem Pharm Bull (Tokyo); 2001 Dec 07; 49(12):1631-5. PubMed ID: 11767086
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.